GLP1R and type 2 diabetes mellitus: In T2DM mice, dapagliflozin promotes the production of GLP-1 by modulating the gut microbiota and tryptophan metabolism, thereby facilitating beta-cell regeneration and slowing the progression of DM [38,39].